
Nautilus Biotechnology, Inc.: shareholders and insiders
Price
$2.12
November 20, 2026Market cap $268M
What Ploutos Investor adds for Nautilus Biotechnology
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 27% since Oct 27, 2026, when the 10-Q these figures come from was filed ($2.89 then, $2.12 on Nov 20, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors from Nov 22, 2025 to Jun 22, 2026, from their own Form 4 filings.
Bought on the market
$65.3K
1 person
Sold on the market
$12M
1 person
From Nov 22, 2025 to Nov 22, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 22, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $65.3K by 1 person·sold $12M by 1 person
- 2025: no buys, no sales
- 2026: bought $65.3K by 1 person, sold $12M by 1 person
- Jun 2, 2026AH Equity Partners Bio II, L.L.C.Kind
- Jun 2, 2026AH Equity Partners Bio II, L.L.C.Kind
- Mar 4, 2026Sujal M PatelCEO, President, and SecretaryKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C. | 4.62M | $2.35 | $11M | Form 4 | |
| Jun 2, 2026 | AH Equity Partners Bio II, L.L.C. | 384.0K | $2.35 | $902.5K | Form 4 | |
| Mar 4, 2026 | Sujal M PatelCEO, President, and Secretary | 25.0K | $2.61 | $65.3K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 4, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by NAUT's officers and directors from 2021 up to November 21, 2025, 5 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
Fell to 5% or less (2)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Point72 (Cohen)In the quarter
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter
- Renaissance TechnologiesIn the quarter+134%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Point72 (Cohen) | – | – | 0.00% | |
| Citadel Advisors (Griffin) | – | – | 0.00% | |
| Millennium Mgmt (Englander) | – | – | 0.00% | |
| Renaissance Technologies | 1.62M | +134% | $2.3M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 4.44% of its shares outstanding were held short, -2.6% since the report before.
- Shares held short
- 5.62M
- 4.44%
- Since the report before5.77M on Sep 30, 2026
- -2.6%
- under 1
- 12.60M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 12%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.23M
- Nov 15, 2023: Shares held short 1.37M
- Nov 30, 2023: Shares held short 1.25M
- Dec 15, 2023: Shares held short 1.30M
- Dec 29, 2023: Shares held short 1.32M
- Jan 12, 2024: Shares held short 1.24M
- Jan 31, 2024: Shares held short 1.23M
- Feb 15, 2024: Shares held short 1.23M
- Feb 29, 2024: Shares held short 1.31M
- Mar 15, 2024: Shares held short 1.23M
- Mar 28, 2024: Shares held short 1.20M
- Apr 15, 2024: Shares held short 1.11M
- Apr 30, 2024: Shares held short 1.12M
- May 15, 2024: Shares held short 1.10M
- May 31, 2024: Shares held short 1.09M
- Jun 14, 2024: Shares held short 1.15M
- Jun 28, 2024: Shares held short 1.21M
- Jul 15, 2024: Shares held short 1.17M
- Jul 31, 2024: Shares held short 1.20M
- Aug 15, 2024: Shares held short 1.19M
- Aug 30, 2024: Shares held short 1.18M
- Sep 13, 2024: Shares held short 1.22M
- Sep 30, 2024: Shares held short 1.21M
- Oct 15, 2024: Shares held short 1.21M
- Oct 31, 2024: Shares held short 1.21M
- Nov 15, 2024: Shares held short 1.17M
- Nov 29, 2024: Shares held short 1.17M
- Dec 13, 2024: Shares held short 1.20M
- Dec 31, 2024: Shares held short 1.03M
- Jan 15, 2025: Shares held short 872.9K
- Jan 31, 2025: Shares held short 272.0K
- Feb 14, 2025: Shares held short 283.2K
- Feb 28, 2025: Shares held short 291.6K
- Mar 14, 2025: Shares held short 352.3K
- Mar 31, 2025: Shares held short 424.5K
- Apr 15, 2025: Shares held short 548.9K
- Apr 30, 2025: Shares held short 867.4K
- May 15, 2025: Shares held short 942.2K
- May 30, 2025: Shares held short 1.05M
- Jun 13, 2025: Shares held short 1.23M
- Jun 30, 2025: Shares held short 297.6K
- Jul 15, 2025: Shares held short 241.3K
- Jul 31, 2025: Shares held short 268.2K
- Aug 15, 2025: Shares held short 224.7K
- Aug 29, 2025: Shares held short 225.3K
- Sep 15, 2025: Shares held short 175.2K
- Sep 30, 2025: Shares held short 188.2K
- Oct 15, 2025: Shares held short 180.3K
- Oct 31, 2025: Shares held short 184.2K
- Nov 14, 2025: Shares held short 390.6K
- Nov 28, 2025: Shares held short 420.9K
- Dec 15, 2025: Shares held short 389.4K
- Dec 31, 2025: Shares held short 445.2K
- Jan 15, 2026: Shares held short 368.5K
- Jan 30, 2026: Shares held short 307.3K
- Feb 13, 2026: Shares held short 344.1K
- Feb 27, 2026: Shares held short 392.2K
- Mar 13, 2026: Shares held short 446.7K
- Mar 31, 2026: Shares held short 675.0K
- Apr 15, 2026: Shares held short 638.9K
- Apr 30, 2026: Shares held short 715.6K
- May 15, 2026: Shares held short 825.0K
- May 29, 2026: Shares held short 760.2K
- Jun 15, 2026: Shares held short 541.1K
- Jun 30, 2026: Shares held short 829.5K
- Jul 15, 2026: Shares held short 1.45M
- Jul 31, 2026: Shares held short 2.27M
- Aug 14, 2026: Shares held short 3.15M
- Aug 31, 2026: Shares held short 3.81M
- Sep 15, 2026: Shares held short 4.08M
- Sep 30, 2026: Shares held short 5.77M
- Oct 15, 2026: Shares held short 5.62M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading39.5% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 39.5% of the shares in the reported trades were short sales, against 45.7% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 39.5%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 45.7%
- Change
- -6.2 pts
- Short sales a dayon average, of 2.40M shares
- 947.5K
- More than atof 3,666 US-listed companies, same days
- 18%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 53.1%
- Oct 15, 2026: Short sales 44.3%
- Oct 16, 2026: Short sales 58.3%
- Oct 19, 2026: Short sales 52.8%
- Oct 20, 2026: Short sales 53%
- Oct 21, 2026: Short sales 60.1%
- Oct 22, 2026: Short sales 54.6%
- Oct 23, 2026: Short sales 47.8%
- Oct 26, 2026: Short sales 43.2%
- Oct 27, 2026: Short sales 27.2%
- Oct 28, 2026: Short sales 39.3%
- Oct 29, 2026: Short sales 53%
- Oct 30, 2026: Short sales 42.1%
- Nov 2, 2026: Short sales 44.3%
- Nov 3, 2026: Short sales 49%
- Nov 4, 2026: Short sales 35.5%
- Nov 5, 2026: Short sales 27.1%
- Nov 6, 2026: Short sales 32.9%
- Nov 9, 2026: Short sales 29.1%
- Nov 10, 2026: Short sales 40.2%
- Nov 11, 2026: Short sales 44.2%
- Nov 12, 2026: Short sales 52.6%
- Nov 13, 2026: Short sales 40.2%
- Nov 16, 2026: Short sales 51.5%
- Nov 17, 2026: Short sales 43.5%
- Nov 18, 2026: Short sales 49.7%
- Nov 19, 2026: Short sales 32.3%
- Nov 20, 2026: Short sales 41.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Parag MallickChief ScientistDirectly20.49M
- AH Equity Partners Bio II, L.L.C.Directly12.65M
- Sujal M PatelCEO, President, and SecretaryDirectly10.37M
- AH Bio Fund II, L.P.TenPercentOwnerDirectly–
- Anna MowryCFO and TreasurerDirectly83.0K
- Matthew B. MurphyGeneral CounselDirectly–
- Kentaro SuzukiChief Marketing OfficerDirectly4,000
- Mary E. GodwinSenior VP, OperationsDirectly–
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Parag MallickChief Scientist | 20.49M | – | May 12, 2025 | Form 4 |
| AH Equity Partners Bio II, L.L.C. | 12.65M | – | Jun 2, 2026 | Form 4 |
| Sujal M PatelCEO, President, and Secretary | 10.37M | – | Mar 4, 2026 | Form 4 |
| AH Bio Fund II, L.P.TenPercentOwner | – | 971.9K | Jun 2, 2026 | Form 4 |
| Anna MowryCFO and Treasurer | 83.0K | – | May 29, 2025 | Form 4 |
| Matthew B. MurphyGeneral Counsel | – | 74.1K | Sep 4, 2025 | Form 4 |
| Kentaro SuzukiChief Marketing Officer | 4,000 | – | Nov 6, 2025 | Form 4 |
| Mary E. GodwinSenior VP, Operations | – | – | Sep 23, 2024 | Form 4 |
A lower bound: it counts only the 8 officers and directors with a market trade since Nov 23, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.02%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.01%
- IWMiShares Russell 2000 ETFWeight in the fund0.00%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.00%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- DFACDimensional U.S. Core Equity 2 ETFWeight in the fund0.00%
9 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 68
- Q4 2025: Managers 68
- Q1 2026: Managers 81
- Q2 2026: Managers 93
Institutional investors by quarter
The fund managers holding NAUT, quarter by quarter, from Q2 2021 to Q2 2025, 17 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 93 managers held 50.14M shares, worth $94M. During the quarter 29 opened a position, 18 closed one, 28 added and 11 trimmed.
The largest holders, Q2 2026
- Perceptive AdvisorsIn the quarter-7.6%
- a16z Capital ManagementIn the quarter-49%
- Cercano ManagementIn the quarter
- BlackRockIn the quarter×14.3
- Vanguard Capital ManagementIn the quarter+0.2%
- Comprehensive Financial ManagementIn the quarter
- Citadel Advisors (Griffin)In the quarter
- Geode Capital ManagementIn the quarter+110%
- Acadian Asset ManagementIn the quarter+42%
- Clearstead AdvisorsIn the quarter-62%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Perceptive Advisors | 11.63M | -7.6% | $22M |
| a16z Capital Management | 9.06M | -49% | $17M |
| Cercano Management | 7.17M | $13M | |
| BlackRock | 2.69M | ×14.3 | $5.0M |
| Vanguard Capital Management | 2.55M | +0.2% | $4.8M |
| Comprehensive Financial Management | 2.21M | $4.1M | |
| Citadel Advisors (Griffin) | 1.90M | $3.5M | |
| Geode Capital Management | 1.27M | +110% | $2.4M |
| Acadian Asset Management | 1.06M | +42% | $2.0M |
| Clearstead Advisors | 892.8K | -62% | $1.7M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Nautilus Biotechnology's filings show?
Who buys and sells is one part of Nautilus Biotechnology's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have NAUT's insiders bought or sold?
From Jun 4, 2026 to Jun 22, 2026 Nautilus Biotechnology's insiders bought 0 and sold $12M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold NAUT?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $2.3M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.